[Federal Register: September 29, 1998 (Volume 63, Number 188)]
[Notices]
[Page 51942]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29se98-109]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Good Manufacturing Practices for Dietary Supplements Working
Group of the Food Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
    Name of Committee: Good Manufacturing Practices for Dietary
Supplements Working Group of the Food Advisory Committee.
    General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on October 16, 1998, 9 a.m.
to 4 p.m.
    Location: Ramada Plaza O'Hare, 6600 North Mannheim Rd., Rosemont,
IL.
    Contact Person: Karen F. Strauss, Center for Food Safety and
Applied Nutrition (HFS-456), Food and Drug Administration, 200 C St.
SW., Washington, DC 20204, 202-205-5123, FAX 202-205-5295, or FDA
Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in
the Washington, DC area), code 10564. Please call the Information Line
for up-to-date information on this meeting.
    Agenda: The Working Group will meet to discuss and further develop
a draft report on good manufacturing practices identity testing and
recordkeeping. The draft report will be presented to the food advisory
committee at a later date for public discussion and consideration as
the committee's recommendations to FDA.
    Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by October 8,
1998. Oral presentations from the public will be scheduled between
approximately 9 a.m. and 10 a.m. Time allotted for each presentation
may be limited. Those desiring to make formal oral presentations should
notify the contact person before October 8, 1998, and submit a brief
statement of the general nature of the evidence or arguments they wish
to present, the names and addresses of proposed participants, and an
indication of the approximate time requested to make their
presentation.
    This meeting is open to the public, but space is limited. For the
convenience of the public, a block of 20-sleeping rooms has been set
aside at a special rate on a first-come first-served basis. Members of
the public who wish to reserve one of these rooms should call the hotel
at 847-827-5131 and make reservations before October 8, 1998. The block
is reserved as general public of the U.S. FDA.
    The Commissioner approves the scheduling of meetings at locations
outside of the Washington, DC, area on the basis of the criteria of 21
CFR 14.22 of FDA's regulations relating to public advisory committees.
    Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).

    Dated: September 18, 1998.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 98-25912 Filed 9-28-98; 8:45 am]
BILLING CODE 4160-01-F